Moxifloxacin

The label describes moxifloxacin tablets for adults aged 18 years and older with infections caused by susceptible bacteria.

It should be used only for infections that are proven or strongly suspected to be bacterial. This helps limit drug-resistant bacteria.

• Community acquired pneumonia
• Skin and skin structure infections
• Complicated abdominal infections
• Plague
• Acute sinusitis and flare-ups of chronic bronchitis, only when no alternative exists

The label describes moxifloxacin as a member of the fluoroquinolone class of antibacterial agents.

The label we reviewed does not give more detail on how it works.

This page covers the US label for moxifloxacin tablets taken by mouth, with the dosing the label gives for adults and, where the label says so, children.

This is label-level information, not personal advice. Indian pack labels may differ, and your prescriber's instruction always comes first.

The label describes a tablet taken by mouth once every 24 hours for adults. The length of treatment depends on the type of infection and ranges from a few days to about three weeks.

The label says no dose change is needed for kidney or liver impairment. When switching from the injection to tablets, no adjustment is described.

Doses of antacids, sucralfate and multivitamins are timed apart from the tablet, as described under interactions.

• Taken by mouth once every 24 hours
• Course length depends on the infection
• Space apart from antacids, iron, zinc and similar products
• Follow the prescriber's course length

The label says to stop moxifloxacin immediately and avoid fluoroquinolones if tendon, nerve or central nervous system reactions occur.

It should be avoided in people with a history of myasthenia gravis. It must not be used in anyone allergic to moxifloxacin or other quinolones.

The label advises QT prolongation, blood sugar changes and sun sensitivity as other concerns. Pregnancy data in humans are lacking, and animal studies suggest possible fetal harm.

• Boxed warning: tendon, nerve and brain effects
• Avoid with myasthenia gravis
• Not for anyone allergic to quinolones
• QT prolongation and blood sugar changes
• Sun sensitivity

• Antacids, sucralfate, multivitamins
• Warfarin
• Class IA and III antiarrhythmics
• Diabetes medicines
• Antacids, sucralfate and multivitamins with iron or zinc reduce absorption, so the label says to separate them from the tablet by several hours.
• Warfarin effects can be stronger.
• Certain heart rhythm medicines should be avoided together, and diabetes medicines need blood sugar monitoring.

No match in this label text. Ask your pharmacist about any medicine you take.

The label gives a storage range of 15 to 30 degrees C.

Follow the storage line on your own pack, and keep medicines out of the reach of children.

In the Drugs Rules schedules we checked, moxifloxacin is listed under Schedule H1 (serial and rule: Schedule H1, serial 35 (rules 65 and 97)). Schedule H1 medicines are sold only on a doctor's prescription, and the pharmacy records the sale.

Moxifloxacin is on the National List of Essential Medicines 2022. Listed forms include: Tablet 400 mg (page 74).

NPPA lists ceiling prices for scheduled moxifloxacin formulations. The table shows the rows we found. Check NPPA directly for the current list.

The Jan Aushadhi (PMBJP) list we checked has 5 product rows that mention moxifloxacin. We did not capture prices for them.

NPPA ceiling prices set the most a seller can charge per unit for the listed formulations, before local taxes. They are ceilings, not the price you will always pay.

Jan Aushadhi lists moxifloxacin products including Moxifloxacin Tablets 400 mg 400 mg; Moxifloxacin Hydrochloride Eye Drops IP 0.5% w/v None; Moxifloxacin 0.5% w/v and Dexamethasone 0.1% w/v Eye Drops None; Moxifloxacin 400mg and Cefixime 400mg Tablet 400mg. We have not shown a price for them. Check the pack and the seller for the actual price.